1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014

  • December 2014
  • -
  • Global Markets Direct
  • -
  • 28 pages

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014’, provides an overview of the Shin Nippon Biomedical Laboratories, Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Shin Nippon Biomedical Laboratories, Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Shin Nippon Biomedical Laboratories, Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Shin Nippon Biomedical Laboratories, Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Shin Nippon Biomedical Laboratories, Ltd.’s pipeline products

Reasons to buy

- Evaluate Shin Nippon Biomedical Laboratories, Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Shin Nippon Biomedical Laboratories, Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Shin Nippon Biomedical Laboratories, Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Shin Nippon Biomedical Laboratories, Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Shin Nippon Biomedical Laboratories, Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Shin Nippon Biomedical Laboratories, Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014
Table of Contents
Shin Nippon Biomedical Laboratories, Ltd. Snapshot 5
Shin Nippon Biomedical Laboratories, Ltd. Overview 5
Key Information 5
Key Facts 5
Shin Nippon Biomedical Laboratories, Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products Glance 12
Shin Nippon Biomedical Laboratories, Ltd. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Shin Nippon Biomedical Laboratories, Ltd. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Shin Nippon Biomedical Laboratories, Ltd. - Drug Profiles 15
granisetron 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
zolmitriptan 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
dihydroergotamine mesylate 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Peptide for Cerebral Infarction 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
TR-Flu 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Analysis 21
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products by Target 21
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products by Route of Administration 22
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products by Molecule Type 23
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products by Mechanism of Action 24
Shin Nippon Biomedical Laboratories, Ltd. - Recent Pipeline Updates 25
Shin Nippon Biomedical Laboratories, Ltd. - Locations And Subsidiaries 26
Head Office 26
Other Locations and Subsidiaries 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables

Shin Nippon Biomedical Laboratories, Ltd., Key Information 5
Shin Nippon Biomedical Laboratories, Ltd., Key Facts 5
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Indication, 2014 7
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Stage of Development, 2014 8
Shin Nippon Biomedical Laboratories, Ltd. - Monotherapy Products in Pipeline, 2014 9
Shin Nippon Biomedical Laboratories, Ltd. - Partnered Products in Pipeline, 2014 10
Shin Nippon Biomedical Laboratories, Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
Shin Nippon Biomedical Laboratories, Ltd. - Phase II, 2014 12
Shin Nippon Biomedical Laboratories, Ltd. - Phase I, 2014 13
Shin Nippon Biomedical Laboratories, Ltd. - Preclinical, 2014 14
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Target, 2014 21
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Route of Administration, 2014 22
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Molecule Type, 2014 23
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products by Mechanism of Action, 2014 24
Shin Nippon Biomedical Laboratories, Ltd. - Recent Pipeline Updates, 2014 25
Shin Nippon Biomedical Laboratories, Ltd., Other Locations 26
Shin Nippon Biomedical Laboratories, Ltd., Subsidiaries 26

List of Figures

Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Top 10 Indication, 2014 7
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Stage of Development, 2014 8
Shin Nippon Biomedical Laboratories, Ltd. - Monotherapy Products in Pipeline, 2014 9
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Top 10 Target, 2014 21
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Top 10 Route of Administration, 2014 22
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline by Top 10 Molecule Type, 2014 23
Shin Nippon Biomedical Laboratories, Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014 24

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Macular Edema - Pipeline Review, H2 2016

Macular Edema - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Macular Edema - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema – Pipeline Review, H2 2016, provides an overview of ...

Alliqua BioMedical, Inc. (ALQA) - Financial and Strategic SWOT Analysis Review

Alliqua BioMedical, Inc. (ALQA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Alliqua BioMedical, Inc. (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, ...

Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Entest BioMedical Inc. (Entest BioMedical) is a biomedical research company that develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human medicine. ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.